🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predicting DBS Outcomes in Dystonia Using Wearable Gait Sensors

Recruitingn/aAges 18 Years - 70 YearsAllRuijin Hospital
NCT07323602 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to investigate whether preoperative gait characteristics, measured by wearable sensors, can predict the clinical outcomes of Deep Brain Stimulation (DBS) in patients with dystonia. Participants scheduled for DBS surgery will undergo gait analysis using wearable sensors before the procedure. Clinical assessments, including the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the SF-36 Health Survey, will be conducted preoperatively and postoperatively to evaluate surgical efficacy and quality of life. The study seeks to identify gait biomarkers that correlate with optimal DBS response.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinically diagnosed with primary or isolated dystonia. * Scheduled to undergo bilateral Deep Brain Stimulation (DBS) surgery. * Able to walk independently or with assistance (sufficient to perform gait analysis). * Willing to participate and sign informed consent. Exclusion Criteria: * History of other neurological disorders affecting gait (e.g., stroke, severe neuropathy). * Significant orthopedic issues preventing gait assessment. * Cognitive impairment preventing cooperation with study procedures. * Previous functional neurosurgery.
💊

What it tests

  • Wearable Gait Sensor Analysis
📍

Where

1 site
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy